Literature DB >> 5929469

Study of induced typhoid fever in man. I. Evaluation of vaccine effectiveness.

R B Hornick, T E Woodward, F R McCrumb, M J Snyder, A T Dawkins, J T Bulkeley, F De la Macorra, F A Corozza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5929469

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN: 0066-9458


× No keyword cloud information.
  6 in total

1.  Oral immunization against experimental salmonellosis I. Development of temperature-sensitive mutant vaccines.

Authors:  K J Fahey; G N Cooper
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

2.  The role of endotoxin during typhoid fever and tularemia in man. IV. The integrity of the endotoxin tolerance mechanisms during infection.

Authors:  S E Greisman; R B Hornick; H N Wagner; W E Woodward; T E Woodward
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

3.  Diminished neutrophil oxidative metabolism after phagocytosis of virulent Salmonella typhi.

Authors:  R E Kossack; R L Guerrant; P Densen; J Schadelin; G L Mandell
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

4.  Plasma kallikrein activation and inhibition during typhoid fever.

Authors:  R W Colman; R Edelman; C F Scott; R H Gilman
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

5.  Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.

Authors:  T Aebischer; D Bumann; H J Epple; W Metzger; T Schneider; G Cherepnev; A K Walduck; D Kunkel; V Moos; C Loddenkemper; I Jiadze; M Panasyuk; M Stolte; D Y Graham; M Zeitz; T F Meyer
Journal:  Gut       Date:  2008-04-16       Impact factor: 23.059

6.  Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery.

Authors:  Madushini N Dharmasena; Catherine M Feuille; Carly Elizabeth C Starke; Arvind A Bhagwat; Scott Stibitz; Dennis J Kopecko
Journal:  PLoS One       Date:  2016-09-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.